このページの翻訳は実験的なもので、現在開発中です。お待ちしております！
IDEXX Laboratories バランスシートの健全性
財務の健全性 基準チェック /66
IDEXX Laboratoriesの総株主資本は$1.6B 、総負債は$945.8Mで、負債比率は60.3%となります。総資産と総負債はそれぞれ$3.4Bと$1.8Bです。 IDEXX Laboratoriesの EBIT は$1.1Bで、利息カバレッジ比率41.8です。現金および短期投資は$397.4Mです。
主要情報
60.3%
負債資本比率
US$945.78m
負債
| インタレスト・カバレッジ・レシオ | 41.8x |
| 現金 | US$397.43m |
| エクイティ | US$1.57b |
| 負債合計 | US$1.78b |
| 総資産 | US$3.35b |
財務の健全性に関する最新情報
IDEXX Laboratories (NASDAQ:IDXX) Has A Rock Solid Balance Sheet
Apr 11
IDEXX Laboratories (NASDAQ:IDXX) Seems To Use Debt Rather Sparingly
Dec 15Is IDEXX Laboratories (NASDAQ:IDXX) Using Too Much Debt?
Sep 07These 4 Measures Indicate That IDEXX Laboratories (NASDAQ:IDXX) Is Using Debt Reasonably Well
May 31Here's Why IDEXX Laboratories (NASDAQ:IDXX) Can Manage Its Debt Responsibly
Feb 22Is IDEXX Laboratories (NASDAQ:IDXX) Using Too Much Debt?
Nov 24Recent updates
Here's Why IDEXX Laboratories (NASDAQ:IDXX) Has Caught The Eye Of Investors
Jun 04Should You Think About Buying IDEXX Laboratories, Inc. (NASDAQ:IDXX) Now?
May 21IDEXX Laboratories, Inc. Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next
May 03What IDEXX Laboratories, Inc.'s (NASDAQ:IDXX) P/E Is Not Telling You
Apr 27IDEXX Laboratories (NASDAQ:IDXX) Has A Rock Solid Balance Sheet
Apr 11IDEXX: Strong Recurring Revenues From Consumables, Software But Overvalued (Rating Downgrade)
Apr 08Is It Too Late To Consider Buying IDEXX Laboratories, Inc. (NASDAQ:IDXX)?
Jan 30IDEXX Laboratories: Valuation Rerating Doesn't Seem Justified
Jan 16Here's Why IDEXX Laboratories (NASDAQ:IDXX) Has Caught The Eye Of Investors
Jan 15IDEXX Laboratories, Inc.'s (NASDAQ:IDXX) Shareholders Might Be Looking For Exit
Dec 31IDEXX Laboratories (NASDAQ:IDXX) Seems To Use Debt Rather Sparingly
Dec 15Why IDEXX Laboratories, Inc. (NASDAQ:IDXX) Could Be Worth Watching
Oct 26Here's Why We Think IDEXX Laboratories (NASDAQ:IDXX) Is Well Worth Watching
Oct 10Is IDEXX Laboratories (NASDAQ:IDXX) Using Too Much Debt?
Sep 07Is It Time To Consider Buying IDEXX Laboratories, Inc. (NASDAQ:IDXX)?
Jul 04These 4 Measures Indicate That IDEXX Laboratories (NASDAQ:IDXX) Is Using Debt Reasonably Well
May 31At US$484, Is IDEXX Laboratories, Inc. (NASDAQ:IDXX) Worth Looking At Closely?
Apr 05Here's Why IDEXX Laboratories (NASDAQ:IDXX) Can Manage Its Debt Responsibly
Feb 22Why IDEXX Laboratories, Inc. (NASDAQ:IDXX) Could Be Worth Watching
Jan 05Is IDEXX Laboratories (NASDAQ:IDXX) Using Too Much Debt?
Nov 24When Should You Buy IDEXX Laboratories, Inc. (NASDAQ:IDXX)?
Sep 20IDEXX Laboratories: Outstanding Business, But Valuation Is Key
Aug 15These 4 Measures Indicate That IDEXX Laboratories (NASDAQ:IDXX) Is Using Debt Reasonably Well
Aug 15IDEXX Laboratories Stock Is Very Expensive
Aug 08IDEXX Laboratories Non-GAAP EPS of $1.58 misses by $0.05, revenue of $860.55M misses by $1.57M
Aug 02Are IDEXX Laboratories, Inc. (NASDAQ:IDXX) Investors Paying Above The Intrinsic Value?
Jul 26Here's Why We Think IDEXX Laboratories (NASDAQ:IDXX) Might Deserve Your Attention Today
Jul 12Is It Time To Consider Buying IDEXX Laboratories, Inc. (NASDAQ:IDXX)?
Jun 16IDEXX Laboratories: Great Business, But Still Overvalued
May 25We Think IDEXX Laboratories (NASDAQ:IDXX) Can Manage Its Debt With Ease
May 06Is IDEXX Laboratories, Inc. (NASDAQ:IDXX) Worth US$474 Based On Its Intrinsic Value?
Apr 23With EPS Growth And More, IDEXX Laboratories (NASDAQ:IDXX) Is Interesting
Apr 09Is It Too Late To Consider Buying IDEXX Laboratories, Inc. (NASDAQ:IDXX)?
Mar 07IDEXX Laboratories And Its Real Value
Feb 02財務状況分析
短期負債: IDXXの 短期資産 ( $1.5B ) が 短期負債 ( $956.9M ) を超えています。
長期負債: IDXXの短期資産 ( $1.5B ) が 長期負債 ( $827.7M ) を上回っています。
デット・ツー・エクイティの歴史と分析
負債レベル: IDXXの 純負債対資本比率 ( 35% ) は 満足できる 水準であると考えられます。
負債の削減: IDXXの負債対資本比率は、過去 5 年間で2017.2%から60.3%に減少しました。
債務返済能力: IDXXの負債は 営業キャッシュフロー によって 十分にカバー されています ( 97.4% )。
インタレストカバレッジ: IDXXの負債に対する 利息支払い は EBIT ( 41.8 x coverage) によって 十分にカバーされています。